SKU: B036

Size  
Quantity:
 
Price: make selection(s)
Description
Bevacizumab (5 mg/mL) is an angiogenesis inhibiting monoclonal antibody and is commonly used to treat certain metastatic cancers.

    CAS Number

    216974-75-3

    Molecular Formula

    C6638H10160N1720O2108S44

    Molecular Weight

    149,146.82 g/mol

    Mechanism of Action

    Bevacizumab can inhibit tumor growth in a few different ways including inhibiting new blood vessel growth, altering vascular function and blood flow in tumor, and regression of newly formed tumor vasculature.

    Storage Conditions

    ≤30°C

    Spectrum

    Bevacizumab is effective at treating metastatic colon cancer, lung cancers, renal cancers, ovarian cancers, and breast cancer.

Specifications

    Appearance

    Liquid

References

    References

    Ellis, Lee M. "Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer." Seminars in Oncology 33 (2006)

Other Items In This Category